|1.||Tomomura, Akito: 4 articles (11/2015 - 01/2002)|
|2.||Tomomura, Mineko: 3 articles (11/2015 - 03/2011)|
|3.||Sakagami, Hiroshi: 2 articles (05/2012 - 03/2011)|
|4.||Suda, Naoto: 1 article (05/2012)|
|5.||Hasegawa, Hiroya: 1 article (05/2012)|
|6.||Fujii, Takeru: 1 article (03/2011)|
|7.||Katoh, Setsuko: 1 article (01/2002)|
|8.||Itagaki, Kouki: 1 article (01/2002)|
|9.||Yamada, Hirotaka: 1 article (01/2002)|
|10.||Fujimoto, Kengo: 1 article (01/2002)|
|1.||Muscular Dystrophies (Muscular Dystrophy)
11/26/2015 - "Ectopic intramuscular expression of caldecrin prevented bone resorption in ovariectomized mice. "
05/25/2012 - "Thus, caldecrin is capable of acting as a negative regulator of osteoclastogenesis and osteoclast function of bone resorption."
11/23/2001 - "These results suggest that amino acid sequence corresponding to rat caldecrin (aa 71-79) is responsible for the suppression of bone resorption by caldecrin."
11/26/2015 - "Caldecrin also suppressed the bone resorption activity of mature osteoclasts by preventing RANKL-stimulated Src activation, calcium entry, and actin ring formation. "
11/23/2001 - "The suppressive effect on the bone resorption was not affected by treatment of caldecrin with phenylmethyl sulfonyl fluoride or by use of protease-deficient mutant caldecrins. "
|5.||Body Weight (Weight, Body)
|2.||Serine Proteases (Serine Protease)
|3.||Parathyroid Hormone-Related Protein
|4.||Parathyroid Hormone (Parathormone)
|7.||sulfuryl fluoride (sulfonyl fluoride)